Viewing Study NCT01082250


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2026-05-31 @ 2:58 PM
Study NCT ID: NCT01082250
Status: COMPLETED
Last Update Posted: 2011-09-08
First Post: 2010-03-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Bioequivalence Of Two Different Lurasidone Formulations In Patients
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioequivalence View
None Male/Female Patient View
None Reference/Test Formulation View
None Schizophrenia Patients View